The promise of metabolomics in cancer molecular therapeutics

Current Opinion in Molecular Therapeutics

Volumn 6, Issue 6, 2004, Pages 584-592

  Fan, Teresa W M ^a   Lane, Andrew N ^a   Higashi, Richard M ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemoinformatics; Flux; Isotopomers; Mass spectrometry; Metabolomics; Nuclear magnetic resonance

Indexed keywords

ANALYTIC METHOD; CANCER CELL; CANCER THERAPY; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INSTRUMENTATION; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN FUNCTION; PROTEOMICS; REVIEW;

ANIMALS; GENE THERAPY; GENOMICS; HUMANS; NEOPLASMS; PROTEOMICS;

EID: 11344272281     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Karp G (Ed): Cancer. John Wiley & Sons, New York, NY, USA (2002).
2. Subramanian A, Miller DM: Structural analysis of α-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem (2000) 275 8):5958-5965.
3. Rosen A, Lundman P, Carlsson M, Bhavani K, Srinivasa BR, Kjellstrom G, Nilsson K, Holmgren A: A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int Immunol(1995) 7(4):625-633.
4. Balcewicz-Sablinska MK, Wollman EE, Gortl R, Silberstein DS: Human eosinophil cytotoxicity-enhancing factor II. Multiple forms synthesized by U937 cells and their relationship to thioredoxin adult T cell leukemia-derived factor. J Immunol (1991) 147 7):2170-2174.
5. Jonsson-Videsater K, Bjorkhem-Bergman L, Hossein A, Soderberg A, Eriksson LC, Paul C, Rosen A, Bjornstedt M: Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Biochem Pharmacol (2004) 67(3):513-522.
6. Mazurek S, Eigenbrodt E: The tumor metabolome. Anticancer Res (2003) 23(2A):1149-1154.
7. ter Kuile BH, Westerhoff HV: Transcriptome meets metabolome: Hierarchical and metabolic regulation of the glycolytic pathway. Febs Lett (2001) 500(3):169-171.
8. Fan TWM: Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc (1996) 28:161-219.
9. Fan TWM: Recent advancement in profiling plant metabolites by multinuclear and multi-dimensional NMR. In: Nuclear Magnetic Resonance in Plant Biology. Shachar-Hill Y, Pfeffer PE (Eds), American Society of Plant Physiologists, Rockville, MD, USA (1996 ):181-254.
10. 15N N.M.R. study of nitrogen metabolism in cultured mammalian cells. Biochem J (1993) 291(2 ):485-492.
11. 13C resonances. Biochim Biophys Acta (1984) 805(1):104-116.
12. Fan TWM, Lane AN, Higashi RM: In Vivo and in vitro metabolomic analysis of anaerobic rice colleoptiles revealed unexpected pathways. Russian J Plant Physiol (2003) 50 6):787-793.
13. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci USA (2002) 99 5):2708-2713.
14. de Graaf AA, Eggeling L, Sahm H: Metabolic engineering for L-lysine production by Corynebacterium glutamicum. Adv Biochem Eng Biotechnol (2001) 73:9-29.
15. 2]glucose. Am J Physiol Endocrinol Metab (1998) 274(5 Pt 1):E843-E851.
16. Fan TWM, Higashi RM, Frenkiel TA, Lane AN: Anaerobic nitrate and ammonium metabolism in flood-tolerant rice coleoptiles. J Exp Botany (1997) 48(314):1655-1666.
17. Gadian DG: NMR and its applications to living systems. 2nd Edition, Oxford University Press, Oxford, UK (1995).
18. 31P-NMR driven saturation transfer. Biochim Biophys Acta (1992) 1135(1):44-49.
19. Pillai MC, Vines CA, Wikramanayake AH, Cherr GN: Polycyclic aromatic hydrocarbons disrupt axial development in sea urchin embryos through a β-catenin dependent pathway. Toxicology (2003) 186(1-2):93-108.
20. Olivo M, Lau W, Manivasager V, Hoon TP, Christopher C: Fluorescence confocal microscopy and image analysis of bladder cancer using 5-aminolevulinic acid. Int J Oncol (2003) 22 3):523-528.
21. Croce AC, Spano A, Locatelli D, Barni S, Sciola L, Bottiroli G: Dependence of fibroblast autofluorescence properties on normal and transformed conditions. Role of the metabolic activity. Photochem Photobiol (1999) 69(3):364-374.
22. Lane M, O'Donovan MK, Squires EL, Seidel GE Jr, Gardner DK: Assessment of metabolism of equine morulae and blastocysts. Mol Reprod Dev (2001) 59(1):33-37.
23. Strickland PT, Kang D, Bowman ED, Fitzwilliam A, Downing TE, Rothman N, Groopman JD, Weston A: Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis (1994) 15(3):483-487.
24. Cavanagh J, Fairbrother WJ, Palmer AG, Skelton AG: Protein NMR Spectroscopy: Principles and Practice. Academic Press, San Diego, CA, USA (1996).
25. 13C NMR Spectroscopy. Levy GC (Ed), Wiley Interscience, New York, NY, USA (1984):197-238.
26. Ernst RR, Bodenhausen G, Wokaun A: Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Oxford University Press, Oxford, UK (1990).
27. Fan TWM, Lane AN, Shenker M, Bartley JP, Crowley D, Higashi RM: Comprehensive chemical profiling of gramineous plant root exudates using high-resolution NMR and MS. Phytochemistry (2001) 57 2):209-221.
28. 13C NMR spectroscopy and nonlinear least squares analysis. J Biol Chem (1995) 270 14):7999-8008.
29. Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, Chance EM, Glickson JD: Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids. NMR Biomed (2000) 13(6):349-360.
30. Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E: Pyruvate kinase type M2: A crossroad in the tumor metabolome. Br J Nutr (2002) 87(Suppl 1):S23-S29.
31. 1H NMR and GC: Analysis for organic osmolytes in crude tissue extracts. Anal Biochem (1993) 214(1 ):260-271.
32. Lagarde F, Amran MB, Leroy MJ, Demesmay C, Ollé M, Lamotte A, Muntau H, Michel P, Thomas P, Caroli S, Larsen E et al: Improvement scheme for the determination of arsenic species in mussel and fish tissues. Fresenius J Anal Chem (1999) 363(1 ):5-11.
33. Larsen EH, Hansen M, Fan T, Vahl M: Speciation of selenoamino acids, selenonium ions and inorganic selenium by ion exchange HPLC with mass spectrometric detection and its application to yeast and algae. J Anal Atomic Spectrom (2001) 16(12):1403-1408.
34. Lindon JC, Nicholson JK, Everett JR: NMR spectroscopy of biofluids. In: Annual Reports on NMR Spectroscopy. Academic Press Inc, New York, NY, USA (1999) 38:1-88.
35. Lindon JC, Holmes E, Nicholson JK: So whats the deal with metabonomics? Anal Chem (2003) 75(17):384A-391A.
36. 31P NMR heteronuclear total correlation spectroscopy (heteroTOCSY). Anal Biochem (1998) 263(2 ):139-149.
37. 13C NMR analysis of acyl chain composition and organization of perirenal triacylglycerides in rats fed vegetable and fish oils. J Lipid Res (1994) 35(4):678-689.
38. Fan TWM, Higashi RM, Lane AN: Biotransformations of selenium oxyanion by filamentous cyanophyte-dominated mat cultured from agricultural drainage waters. Environ Sci Technol (1998) 32 20):3185-3193.
39. Bloom M, Holmes KT, Mountford CE, Williams PG: Complete proton magnetic resonance in whole cells. J Magnetic Resonance (1986) 69:73-91.
40. Evanochko WT, Ng TC, Glickson JD: Application of in vivo NMR spectroscopy to cancer. Magn Reson Med (1984) 1 4):508-534.
41. 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning. Cancer Res (2003) 63 24):8813-8820.
42. 1H-NMR assignments. Biochim Biophys Acta (1986) 882(2):154-167.
43. Mountford CE, Wright LC, Holmes KT, Mackinnon WB, Gregory P, Fox RM: High-resolution proton nuclear magnetic resonance analysis of metastatic cancer-cells. Science (1984) 226 4681):1415-1418.
44. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE: Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology (1997) 204(3):661-666.
45. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE: The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat (2001) 68(1):45-54.
46. Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, Mountford CE, Russell P: Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology (2002) 34(5):417-422.
47. Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, Russell P, Barraclough B, Gillett D, Himmelreich U, Dolenko B, Nikulin AE, Smith IC: Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg (2001) 88 9):1234-1240.
48. Brindle KM: Detection of apoptosis in tumors using magnetic resonance imaging and spectroscopy. Adv Enzyme Regul (2002) 42:101-112.
49. Chung YL, Troy H, Banerji U, Jackson LE, Walton MI, Stubbs M, Griffiths JR, Judson IR, Leach MO, Workman P, Ronen SM: Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. J Natl Cancer Inst (2003) 95 21):1624-1633.
50. Beauregard DA, Pedley RB, Hill SA, Brindle KM: Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS. NMR Biomed (2002) 15(2):99-105.
51. McSheehy PMJ, Troy H, Kelland LR, Judson IR, Leach MO, Griffiths JR: Increased tumour extracellular pH induced by bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics. Eur J Cancer (2003) 39 4):532-540.
52. 1H NMR spectroscopy in vivo, ex vivo, and in vitro. J Biol Chem (2003) 278(46 ):45915-45923.
53. Griffiths JR, McSheehy PM, Robinson SP, Troy H, Chung YL, Leek RD, Williams KJ, Stratford IJ, Harris AL, Stubbs M: Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wildtype tumors and tumors deficient in hypoxia-inducible factor-1β (HIF-1β): Evidence of an anabolic role for the HIF-1 pathway. Cancer Res (2002) 62(3):688-695.
54. Fan TWM, Bandura L, Wysoczynski M, Ratajczak M, Thomas S, Miller D, Higashi RM, Lane AN: Anticancer effects of selenium: Linkage from metabolome to signal transduction. Proc Am Assoc Cancer Res (2004) 95:Abs 1380.